North R J, Bursuker I
J Exp Med. 1984 May 1;159(5):1295-311. doi: 10.1084/jem.159.5.1295.
It was shown that the progressive growth of the immunogenic meth A fibrosarcoma in its semisyngeneic host results in the generation of concomitant immunity to the growth of a tumor implant. The generation of immunity occurred between days 6 and 9 of tumor growth and was associated with the generation of sensitized T cells that were capable, on passive transfer, of causing regression of a 3-d tumor in gamma-irradiated recipients. After day 9 of tumor growth, concomitant immunity and the T cells able to passively transfer it were progressively lost, and this was associated with the generation of splenic suppressor T cells able to suppress the expression of adoptive immunity against an established tumor in T cell-deficient ( TXB ) recipients. The T cells that passively transferred concomitant immunity were shown to be of the Ly-1-2+ phenotype, in contrast to the T cells that transferred suppression, which were shown with the same reagents to be Ly-1+2-. The results are consistent with the hypothesis that the progressive growth of an immunogenic tumor results in the generation of Ly-1-2+-sensitized effector T cells that fail to reach a number sufficient to destroy the tumor because their generation is down-regulated by tumor-induced Ly-1+2- suppressor T cells.
研究表明,免疫原性甲种纤维肉瘤在其半同基因宿主体内的渐进性生长会导致对肿瘤移植生长产生伴随免疫。免疫的产生发生在肿瘤生长的第6天至第9天之间,并且与致敏T细胞的产生相关,这些致敏T细胞在被动转移时能够使γ射线照射的受体中的3日龄肿瘤消退。肿瘤生长第9天后,伴随免疫和能够被动转移它的T细胞逐渐丧失,这与脾抑制性T细胞的产生相关,这些脾抑制性T细胞能够抑制T细胞缺陷(TXB)受体中针对已建立肿瘤的过继免疫的表达。与转移抑制作用的T细胞相反,被动转移伴随免疫的T细胞显示为Ly-1-2 +表型,使用相同试剂显示转移抑制作用的T细胞为Ly-1 + 2-。这些结果与以下假设一致:免疫原性肿瘤的渐进性生长导致Ly-1-2 +致敏效应T细胞的产生,由于其产生受到肿瘤诱导的Ly-1 + 2-抑制性T细胞的下调,这些T细胞数量不足以破坏肿瘤。